431 related articles for article (PubMed ID: 34322134)
1. Shared Pathogenetic Features Between Common Variable Immunodeficiency and Sjögren's Syndrome: Clues for a Personalized Medicine.
Quartuccio L; De Marchi G; Longhino S; Manfrè V; Rizzo MT; Gandolfo S; Tommasini A; De Vita S; Fox R
Front Immunol; 2021; 12():703780. PubMed ID: 34322134
[TBL] [Abstract][Full Text] [Related]
2. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
Ampélas JF; Wattiaux MJ; Van Amerongen AP
Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
[TBL] [Abstract][Full Text] [Related]
3. Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectives.
Idborg H; Zandian A; Sandberg AS; Nilsson B; Elvin K; Truedsson L; Sohrabian A; Rönnelid J; Mo J; Grosso G; Kvarnström M; Gunnarsson I; Lehtiö J; Nilsson P; Svenungsson E; Jakobsson PJ
Arthritis Res Ther; 2019 Feb; 21(1):62. PubMed ID: 30777133
[TBL] [Abstract][Full Text] [Related]
4. Biosemantics guided gene expression profiling of Sjögren's syndrome: a comparative analysis with systemic lupus erythematosus and rheumatoid arthritis.
Shah NR; Noll BD; Stevens CB; Brennan MT; Mougeot FB; Mougeot JC
Arthritis Res Ther; 2017 Aug; 19(1):192. PubMed ID: 28818099
[TBL] [Abstract][Full Text] [Related]
5. [Association of systemic lupus erythematosus and Sjögren's syndrome].
Szántó A; Kiss E; Sas A; Szegedi G; Zeher M
Orv Hetil; 2005 Dec; 146(50):2533-8. PubMed ID: 16440498
[TBL] [Abstract][Full Text] [Related]
6. Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus.
Szanto A; Szodoray P; Kiss E; Kapitany A; Szegedi G; Zeher M
Hum Immunol; 2006 Nov; 67(11):924-30. PubMed ID: 17145372
[TBL] [Abstract][Full Text] [Related]
7. [Sjögren's syndrome].
Witte T
Z Rheumatol; 2014 Feb; 73(1):49-61. PubMed ID: 24554256
[TBL] [Abstract][Full Text] [Related]
8. Translational Mini-Review Series on B cell subsets in disease. Transitional B cells in systemic lupus erythematosus and Sjögren's syndrome: clinical implications and effects of B cell-targeted therapies.
Vossenkämper A; Lutalo PM; Spencer J
Clin Exp Immunol; 2012 Jan; 167(1):7-14. PubMed ID: 22132879
[TBL] [Abstract][Full Text] [Related]
9. Involvement of human intracisternal A-type retroviral particles in autoimmunity.
Sander DM; Szabo S; Gallaher WR; Deas JE; Thompson JJ; Cao Y; Luo-Zhang H; Liu LG; Colmegna I; Koehler J; Espinoza LR; Alexander SS; Hart DJ; Tom DM; Fermin CD; Jaspan JJ; Kulakosky PC; Tenenbaum SA; Wilson RB; Garry RF
Microsc Res Tech; 2005 Nov; 68(3-4):222-34. PubMed ID: 16276517
[TBL] [Abstract][Full Text] [Related]
10. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies to small nuclear ribonucleoproteins. A strong association between anti-SS-B(La), HLA-B8, and Sjögren's syndrome.
Whittingham S; Mackay IR; Tait BD
Aust N Z J Med; 1983 Dec; 13(6):565-70. PubMed ID: 6609699
[TBL] [Abstract][Full Text] [Related]
12. Clinical and immunological parameters of Sjögren's syndrome.
Psianou K; Panagoulias I; Papanastasiou AD; de Lastic AL; Rodi M; Spantidea PI; Degn SE; Georgiou P; Mouzaki A
Autoimmun Rev; 2018 Oct; 17(10):1053-1064. PubMed ID: 30103041
[TBL] [Abstract][Full Text] [Related]
13. Histologic lesion in labial salivary glands of patients with systemic lupus erythematosus.
Skopouli F; Siouna-Fatourou H; Dimou GS; Galanopoulou D; Papadimitriou CS; Moutsopoulos HM
Oral Surg Oral Med Oral Pathol; 1991 Aug; 72(2):208-12. PubMed ID: 1923400
[TBL] [Abstract][Full Text] [Related]
14. Dry eyes: autoimmunity and relationship to other systemic disease.
Maddison PJ
Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 4)():458-61. PubMed ID: 3898478
[TBL] [Abstract][Full Text] [Related]
15. Involvement of Aquaporins in the Pathogenesis, Diagnosis and Treatment of Sjögren's Syndrome.
Soyfoo MS; Chivasso C; Perret J; Delporte C
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380700
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome.
Waterman SA; Gordon TP; Rischmueller M
Arthritis Rheum; 2000 Jul; 43(7):1647-54. PubMed ID: 10902771
[TBL] [Abstract][Full Text] [Related]
17. Association of hippocampal atrophy with cerebrospinal fluid antibodies against the NR2 subtype of the N-methyl-D-aspartate receptor in patients with systemic lupus erythematosus and patients with primary Sjögren's syndrome.
Lauvsnes MB; Beyer MK; Kvaløy JT; Greve OJ; Appenzeller S; Kvivik I; Harboe E; Tjensvoll AB; Gøransson LG; Omdal R
Arthritis Rheumatol; 2014 Dec; 66(12):3387-94. PubMed ID: 25156222
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to alpha-fodrin in primary Sjögren's syndrome and SLE detected by an in vitro transcription and translation assay.
Nordmark G; Rorsman F; Rönnblom L; Cajander S; Taussig MJ; Kämpe O; Winqvist O
Clin Exp Rheumatol; 2003; 21(1):49-56. PubMed ID: 12673889
[TBL] [Abstract][Full Text] [Related]
19. Sjögren's syndrome and systemic lupus erythematosus: links and risks.
Pasoto SG; Adriano de Oliveira Martins V; Bonfa E
Open Access Rheumatol; 2019; 11():33-45. PubMed ID: 30774485
[TBL] [Abstract][Full Text] [Related]
20. Sjögren's syndrome in dermatology.
Fox RI; Liu AY
Clin Dermatol; 2006; 24(5):393-413. PubMed ID: 16966020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
